Dr. Han Zendman, COO at Nytor BV
Invited speaker at iMNC2020 Nano4Health
Organisation: Nytor BV
Dr. Han Zendman studied Molecular Sciences at the Wageningen University (NL; 1989-1995). Next achieved a PhD (1995-2002) in Melanoma skin cancer gene expression research (Radboud UMC, Nijmegen, NL) followed by a Postdoc (2002-2007) on autoimmunicity in Rheumatoid Arthritis (Radboud UMC, Nijmegen, NL). In 2007 started at FutureDiagnostics (Wijchen, NL) as project leader in immunoassay development. Switched to project leader molecular assay-development at NYtor in 2013, currently in Chief Operating Officer (COO) position.